Accumulation of RNA in the nucleus is one of the pathological features of C9orf72-associated 26 amyotrophic lateral sclerosis and frontotemporal dementia (C9-ALS/FTD), yet its potential 27 42 Staufen, may also be an important pathological feature of C9-ALS/FTD. 43 44 45 46 47 3 48 Author summary 49 Cytoplasmic accumulation of nuclear RNA-binding proteins (RBPs) is one of the common 50 pathological features of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia 51 (FTD). In C9orf72-associated ALS/FTD fly model, we found that Staufen, a double-stranded 52 (ds) RBP normally localized mostly in cytoplasm, accumulates in the nucleus in an RNA-53 dependent manner. Next, we checked wherein the nucleus Staufen accumulates and found that 54 Staufen partially co-localizes with heterochromatin and nucleolus. Interestingly, the expression 55 of Fibrillarin, a nucleolar protein, was significantly increased by C9orf72-derived PR toxicity 56 and further augmented by reduction in stau dosage, the gene encoding Staufen. When we 57 knocked down fib, the gene encoding Fibrillarin, PR-induced retinal degeneration was 58 exacerbated. This indicates that increased Fibrillarin expression by stau dosage reduction is 59 protective. Furthermore, when we reduced stau dosage in flies presenting PR toxicity, their 60 retinal degeneration and viability were largely rescued. Based on these data, we suggest that 61 nuclear accumulation of Staufen is an important feature of C9-ALS/FTD and suggest that 62 reducing stau dosage is a promising therapeutic target.
toxic cellular consequences remain largely undefined. RNA accumulated in the nucleus may 28 interact with and increase nuclear localization of RNA-binding proteins (RBPs). Here, we show 29 in C9-ALS/FTD Drosophila melanogaster model that Staufen, a double-stranded RBP 30 normally localized in cytoplasm, accumulates in the nucleus, which is in contrast to many 31 nuclear-localized RBPs, such as TDP-43 and FUS, whose cytoplasmic accumulation is thought 32 to be a pathological hallmark of ALS/FTD. We found that in Drosophila neurons expressing 33 arginine-rich dipeptide repeat proteins (DPRs), Staufen accumulated in the nucleus in an RNA-34 dependent manner. In the nucleus, Staufen localized closely to, and potentially interacts with, 35 heterochromatin and nucleolus in Drosophila C4 da neurons expressing poly(PR), a proline-36 arginine (PR) DPR. PR toxicity in C4 da neurons increased Fibrillarin staining in the nucleolus, 37 which was enhanced by stau heterozygous mutation. Furthermore, knockdown of fib 38 exacerbated retinal degeneration mediated by PR toxicity, which suggests that increased 39 amount of Fibrillarin by stau heterozygous mutation is protective. Heterozygotic mutation of 40 stau could also mitigate retinal degeneration and rescue viability of flies exhibiting PR toxicity. 41 Taken together, our data show that nuclear accumulation of cytoplasmic protein, such as Introduction 73 Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two diseases on 74 a single pathogenic spectrum with overlapping genetic etiologies [1] . GGGGCC (G 4 C 2 ) repeat 75 expansion mutation in the intron of C9orf72 is the most common cause of both familial and 76 sporadic cases of ALS and FTD (C9-ALS/FTD) [2, 3] . G 4 C 2 repeat expansion produces both 77 sense (G 4 C 2 ) and antisense (G 2 C 4 ) RNAs that can either form toxic nuclear foci [4, 5] or 78 undergo repeat-associated non-ATG translation (RANT) in the cytoplasm to generate five 79 types of dipeptide repeat proteins (DPRs) [6, 7] : glycine-alanine (GA), glycine-proline (GP), 80 glycine-arginine (GR), proline-arginine (PR), and proline-alanine (PA). Among them, 81 arginine-rich DPRs have been shown to be most toxic in fly and mammalian models for ALS 82 [8] . 83 In recent years, nucleocytoplasmic transport defect, which includes decreases in 84 protein import into and mRNA export from the nucleus, has been identified as one of the 85 prominent pathogenic features of C9-ALS/FTD [9] [10] [11] [12] , leading to accumulation of proteins in 86 the cytoplasm and mRNA in the nucleus, respectively. In addition, recent studies showed 87 nuclear accumulation of double-stranded RNA (dsRNA) in tdp-1-deleted C. elegans [13] and 88 in PR-expressing mouse cortical neurons [14] . Currently, potentially toxic consequences of 89 decreased protein import are actively being explored, one of which is cytoplasmic mis- 125 To identify potential RNA-binding proteins (RBPs) that show increased nuclear localization in 126 C9-ALS/FTD Drosophila model, we screened in C4 da neurons, which was recently used to 127 model ALS in flies [19] , for RBPs whose accumulation in the nucleus was increased compared 128 to the controls. For the screen, we used as C9-ALS/FTD Drosophila model the flies that 129 expressed PR repeat proteins (V5-PR36) and not GR repeat proteins, because recent studies 130 showed that between the two arginine-rich DPRs, PR is more closely associated with 131 nucleocytoplasmic transport defects [10, 20, 21]. In addition, by using V5-PR36, which is 132 expressed from an alternative codon different from repeated G 4 C 2 sequence, we were able to 133 preclude detection of RBPs mis-localized by G 4 C 2 RNA from the screen. 134 The genetic screen identified Staufen as the RBP whose accumulation in the nucleus 135 increased most significantly. In control (CTRL) C4 da neurons, GFP-tagged Staufen showed 136 mostly cytoplasmic localization with small puncta in the nucleus, whereas in C4 da neurons 137 expressing V5-PR36, GFP-Staufen puncta were much more prominent in the nucleus ( Fig 1A) . 138 We then quantitatively measured the mean intensity (y-axis) and counted pixel numbers (x-139 axis) for nuclear GFP-Staufen puncta in controls and in C4 da neurons expressing V5-PR36 140 and plotted their relative values ( Fig 1B) . V5-PR36-expressing C4 da neurons showed puncta 141 with substantially higher mean fluorescence intensity (i.e. higher density) and pixel number 142 (i.e. larger size) compared to those in controls. To estimate relative amount of GFP-Staufen 143 proteins in the nucleus of neurons with or without V5-PR36 expression, we multiplied the mean 144 fluorescence intensity with the pixel number of GFP-Staufen puncta. C4 da neurons expressing 145 V5-PR36 showed significantly (p = 0.0022) higher amount of Staufen proteins in the nucleus 146 compared to the controls ( Fig 1C) . . We hypothesized based on this 168 previous study that Staufen, which is a dsRNA-binding protein (dsRBP), may be recruited to 169 the heterochromatin region, a site of dsRNA production, in neurons presenting PR36 toxicity. 170 To test this hypothesis, we expressed RFP-tagged HP1, a Drosophila ortholog of HP1, and 171 compared its co-localization pattern with GFP-Staufen with or without PR36 expression in C4 8 172 da neurons (Fig 2A and 2B ). C4 da neurons with PR36 expression showed that greater fraction 173 of HP1 puncta co-localized with GFP-Staufen puncta than in controls (p = 0.0339) ( Fig 2C) . 174 Consistently, GFP-Staufen partially co-localized with 4′, 6-diamidino-2-phenylindole (DAPI), 175 which labels heterochromatin, in C4 da neurons expressing V5-PR36 ( Fig 2D and E) . These knockdown by itself showed no toxicity ( Fig 4C) . Interestingly, a previous study showed that 235 knockdown of Fib can also exacerbate GR-induced retinal degeneration in Drosophila [32] . 236 These data suggest that a partial loss of stau increases the level of Fibrillarin, which may be a 237 compensatory response to, and not a toxic feature of, PR toxicity.
Results
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239
Heterozygous loss of stau rescues PR toxicity in Drosophila 240 We showed above that in neurons expressing V5-PR36, Staufen partially overlaps with 241 Fibrillarin in the nucleolus and that reducing the dosage of stau increases the amount of 242 Fibrillarin, which may be a compensatory response to PR toxicity. If this is the case, we 243 hypothesized that reducing stau gene dosage might mitigate PR toxicity. To test this hypothesis, Consistent with our hypothesis, stau heterozygous mutation was able to suppress PR36-248 induced retinal degeneration ( Fig 5A) . 249 Next, we asked whether stau heterozygous mutation could increase viability of flies 250 expressing V5-PR36. We measured the percentage of larvae (Genotypes. stau +/-: stau ry9/+ ; elav- In this study, we found that PR expression led to increased staining of Fibrillarin. What 293 might best account for the increased amount of Fibrillarin by PR toxicity? A previous study 294 identified p53 as a repressor of FBL (which codes Fibrillarin protein) promoter, thereby 295 regulating the amount of Fibrillarin, in various cancer cell lines [35] . Interestingly, another 296 study showed that dsRNA induces reduction of p53 in HT1080 cells [36] . These pieces of data 297 suggest that increased dsRNA production by PR toxicity may reduce p53, thereby disinhibiting 298 Fibrillarin production. Furthermore, we found that heterozygous mutation of stau enhanced the 299 level of Fibrillarin in C4 da neurons expressing V5-PR36, which appears to be a compensatory 300 mechanism against PR toxicity. However, how heterozygous mutation of stau induces 301 increased level of Fibrillarin remains unknown. Interestingly, a previous study showed that 302 knockdown of STAU1 led to reduced half-life of TP53 (a human homolog of p53) mRNA in 303 H1299 cells upon actinomycin D treatment [37] . Based on this study, we speculate that in C4 304 da neurons expressing V5-PR36, heterozygous stau mutation may have decreased p53 level, 305 with subsequent increased Fibrillarin production. In contrast to our speculation, a previous 306 study showed that treatment of a high dose (10μmol/L) of PR 20 in SH-SY5Y cells led to 307 increased level of p53, albeit with a significant amount of cell death [38] . Thus, further studies 308 are required for a potential role of p53 in mediating Staufen-dependent PR toxicity. Samples were incubated in 20 g/ml of RNase A (Sigma, R6513) suspended in 1X PBS for 1 422 hr at 37 ℃ before fixation. As controls, samples were incubated in 1X PBS instead of RNase 423 A for 1 hr at 37 ℃ before fixation. The next steps of IHC were performed as described above. 
